Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Outlook Therapeutics (OTLK)

Outlook Therapeutics Inc (OTLK) - logo korporat

Outlook Therapeutics is scaling the production of ophthalmological agents, aiming for global expansion with minimal costs. In the long term, the business relies on the market launch of FDA-approved bevacizumab for the treatment of AMD. Quarterly earnings per share dynamics visualize this potential, with 90.00 showing the level of this metric. Current growth is constrained by a dependence on external contract manufacturing.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Outlook Therapeutics Inc (OTLK): kanggo periode 04.07.2022 - 16.11.2026

outlooktherapeutics.com - rincian analitis lan metrik utama (OTLK)

Pambiji fundamental:Outlook Therapeutics
Produk dadi Outlook Therapeutics

For the biopharmaceutical sector of Outlook Therapeutics (OTLK), where the registration of Lytenava is complicated by FDA rejections and a liquidity shortage, profit dynamics become a critical marker for survival. Analyzing the quarterly growth rate of net income per share allows for an assessment of the pace of yield changes relative to previous periods, determining the business's margin of safety and the risk of capital freeze should operational momentum fade.

Analisis perusahaan pesaing

Alcon Corp (ALC) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Bausch Health (BLCO)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan glaukos.com|Apellis Pharmaceuticals (APLS) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan BLTE|OCUL - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan HROW (Harrow Inc)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Viridian Corp (VRDN)|LENZ - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Oculis - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|EyePoint Pharmaceuticals (EYPT) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Kodiak Sciences Inc (KOD) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan ALDX|KALA: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan IRD|OKYO: Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Adverum Biotechnologies ADVM|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Clearside Biomedical, Inc. (CLSD)|NBY - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPRX (kiorapharma.com)|Alimera Sciences (ALIM) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Eyenovia Inc. - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|GHSI (Guardion Health Sciences) - Wutah bathi EPS kuartalan|Ocuphire Pharma - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan OPT (Opthea)